Literature DB >> 21228239

Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.

R Bodewes1, J H C M Kreijtz, M M Geelhoed-Mieras, G van Amerongen, R J Verburgh, S E van Trierum, T Kuiken, R A M Fouchier, A D M E Osterhaus, G F Rimmelzwaan.   

Abstract

Infection with seasonal influenza viruses induces a certain extent of protective immunity against potentially pandemic viruses of novel subtypes, also known as heterosubtypic immunity. Here we demonstrate that infection with a recent influenza A/H3N2 virus strain induces robust protection in ferrets against infection with a highly pathogenic avian influenza virus of the H5N1 subtype. Prior H3N2 virus infection reduced H5N1 virus replication in the upper respiratory tract, as well as clinical signs, mortality, and histopathological changes associated with virus replication in the brain. This protective immunity correlated with the induction of T cells that cross-reacted with H5N1 viral antigen. We also demonstrated that prior vaccination against influenza A/H3N2 virus reduced the induction of heterosubtypic immunity otherwise induced by infection with the influenza A/H3N2 virus. The implications of these findings are discussed in the context of vaccination strategies and vaccine development aiming at the induction of immunity to pandemic influenza.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228239      PMCID: PMC3067975          DOI: 10.1128/JVI.02371-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Authors:  Suzanne L Epstein
Journal:  J Infect Dis       Date:  2005-11-21       Impact factor: 5.226

2.  Pathogenesis of influenza A (H5N1) virus infection in a primate model.

Authors:  G F Rimmelzwaan; T Kuiken; G van Amerongen; T M Bestebroer; R A Fouchier; A D Osterhaus
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells.

Authors:  K A Benton; J A Misplon; C Y Lo; R R Brutkiewicz; S A Prasad; S L Epstein
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

4.  Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets.

Authors:  S H Seo; R G Webster
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.

Authors:  Elena A Govorkova; Jerold E Rehg; Scott Krauss; Hui-Ling Yen; Yi Guan; Malik Peiris; Tien D Nguyen; Thi H Hanh; Pilipan Puthavathana; Hoang T Long; Chantanee Buranathai; Wilina Lim; Robert G Webster; Erich Hoffmann
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.

Authors:  Emmie de Wit; Vincent J Munster; Monique I J Spronken; Theo M Bestebroer; Chantal Baas; Walter E P Beyer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine.

Authors:  G F Rimmelzwaan; M Baars; R van Beek; P de Lijster; J C de Jong; E C Claas; A D Osterhaus
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641

8.  Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice.

Authors:  Eduardo O'Neill; Scott L Krauss; Janice M Riberdy; Robert G Webster; David L Woodland
Journal:  J Gen Virol       Date:  2000-11       Impact factor: 3.891

9.  Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Authors:  Matthew R Sandbulte; Gretchen S Jimenez; Adrianus C M Boon; Larry R Smith; John J Treanor; Richard J Webby
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

Review 10.  Avian influenza A (H5N1) age distribution in humans.

Authors:  Matthew Smallman-Raynor; Andrew D Cliff
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more
  50 in total

1.  Airborne transmission of influenza A/H5N1 virus between ferrets.

Authors:  Sander Herfst; Eefje J A Schrauwen; Martin Linster; Salin Chutinimitkul; Emmie de Wit; Vincent J Munster; Erin M Sorrell; Theo M Bestebroer; David F Burke; Derek J Smith; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

2.  On the extinction probability in models of within-host infection: the role of latency and immunity.

Authors:  Ada W C Yan; Pengxing Cao; James M McCaw
Journal:  J Math Biol       Date:  2016-01-09       Impact factor: 2.259

3.  Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.

Authors:  Rogier Bodewes; Pieter L A Fraaij; Martina M Geelhoed-Mieras; Carel A van Baalen; Harm A W M Tiddens; Annemarie M C van Rossum; Fiona R van der Klis; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Does exposure to poultry and wild fowl confer immunity to H5N1?

Authors:  Yang Wan; Shaman Jeffrey
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

5.  Transmission dynamics of influenza in two major cities of Uganda.

Authors:  Wan Yang; Matthew J Cummings; Barnabas Bakamutumaho; John Kayiwa; Nicholas Owor; Barbara Namagambo; Timothy Byaruhanga; Julius J Lutwama; Max R O'Donnell; Jeffrey Shaman
Journal:  Epidemics       Date:  2018-03-19       Impact factor: 4.396

6.  Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.

Authors:  Karen L Laurie; William Horman; Louise A Carolan; Kok Fei Chan; Daniel Layton; Andrew Bean; Dhanasekaran Vijaykrishna; Patrick C Reading; James M McCaw; Ian G Barr
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

7.  Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population.

Authors:  Elisabeth Huijskens; John Rossen; Paul Mulder; Ruud van Beek; Hennie van Vugt; Johannes Verbakel; Guus Rimmelzwaan; Marion Koopmans; Marcel Peeters
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

Review 8.  From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Authors:  Carole Henry; Anna-Karin E Palm; Florian Krammer; Patrick C Wilson
Journal:  Trends Immunol       Date:  2017-08-31       Impact factor: 16.687

9.  Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.

Authors:  Attapon Kamlangdee; Brock Kingstad-Bakke; Jorge E Osorio
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

10.  T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.

Authors:  Junwei Li; Maria T Arévalo; Yanping Chen; Shan Chen; Mingtao Zeng
Journal:  Int J Infect Dis       Date:  2014-08-27       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.